← Eichor
Condition: Mature B Cell Malignancies Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Mature B Cell Malignancies

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Evaluation of Human Immune Responses Vaccination in Patients With Lymphoma
Phase N/A · 2 location(s) · Emory University · NCT03501576A Study to Evaluate Glofitamab Monotherapy and Glofitamab + Chemoimmunotherapy in Pediatric and Young Adult Participants
Phase 1/Phase 2 · 30 location(s) · Hoffmann-La Roche · NCT05533775Study of SGR-1505 in Mature B-Cell Neoplasms
Phase 1 · 36 location(s) · Schrödinger, Inc. · NCT05544019Liquid Biopsy in Mature B-cell Tumors
Phase N/A · 1 location(s) · Oncology Institute of Southern Switzerland · NCT03280394The Study of ICP-248 in Patients With Mature B-cell Malignancies
Phase 1 · 22 location(s) · Beijing InnoCare Pharma Tech Co., Ltd. · NCT05728658Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of ICP-248 as Monotherapy or in Combinatio
Phase 1 · 8 location(s) · InnoCare Pharma Inc. · NCT06351527Auto Stem Cell Transplant for Lymphoma Patients
Phase 2 · 1 location(s) · Masonic Cancer Center, University of Minnesota · NCT03125642Obinutuzumab and ICE Chemotherapy in Refractory/Recurrent CD20+ Mature NHL
Phase 2 · 1 location(s) · New York Medical College · NCT02393157A Study of AZD0486 Monotherapy or in Combination With Other Anti-Cancer Agents for Mature B-Cell Malignancies
Phase 1/Phase 2 · 64 location(s) · AstraZeneca · NCT06564038Safety and Efficacy Study of Zamtocabtagene Autoleucel (MB-CART2019.1) in Pediatric Patients With R/R B-Cell Neoplasms
Phase 2 · 5 location(s) · Miltenyi Biomedicine GmbH · NCT06508931B-cell Mature Non-Hodgkin's Lymphoma Treatment Protocol in Children and Adolescents 2021
Phase 4 · 1 location(s) · Federal Research Institute of Pediatric Hematology, Oncology · NCT05518383Phase 1 Trial of BTM-3566 in Relapsed/Refractory Mature B Cell Lymphomas
Phase 1 · 2 location(s) · Bantam Pharmaceuticals · NCT06792734A Study Evaluating the Safety and Efficacy of AUR108 in Patients With Relapsed Advanced Lymphomas (ASHA-1)
Phase 1 · 27 location(s) · Aurigene Discovery Technologies Limited · NCT05984147A Study of CD19 Targeted CAR T Cell Therapy in Pediatric Patients With Relapsed or Refractory B Cell Acute Lymphoblastic
Phase 1 · 8 location(s) · Autolus Limited · NCT06173518A Study of ARV-393 in Relapsed/Refractory Non-Hodgkin Lymphoma.
Phase 1 · 17 location(s) · Arvinas Inc. · NCT06393738
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.